Principal Investigator, MRC Toxicology Unit
James Thaventhiran studies how responding adaptive immune lymphocytes avoid the anti-proliferative signals of inflammation. Learn more.
Research AreasAdaptive immunity
Immunogenetics
Immunotherapy
|
TechniquesPreclinical models
Human phenotyping
Single cell RNA sequencing
Next generation sequencing
|
Areas for CollaborationEcology
|
Research Themes
